Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $9.28 USD
Change Today -0.31 / -3.23%
Volume 14.1K
IRIX On Other Exchanges
Symbol
Exchange
NASDAQ GM
As of 8:10 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Snapshot

Open
$9.05
Previous Close
$9.59
Day High
$9.50
Day Low
$9.05
52 Week High
03/18/15 - $11.28
52 Week Low
10/22/14 - $6.41
Market Cap
93.1M
Average Volume 10 Days
17.5K
EPS TTM
$0.96
Shares Outstanding
10.0M
EX-Date
--
P/E TM
9.7x
Dividend
--
Dividend Yield
--
Current Stock Chart for IRIDEX CORP (IRIX)

Related News

No related news articles were found.

iridex corp (IRIX) Related Businessweek News

No Related Businessweek News Found

iridex corp (IRIX) Details

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company offers laser consoles, such as visible (yellow) photocoagulator consoles, visible (Green) photocoagulator consoles, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations; and ophthalmic delivery devices and other products, including TxCell scanning laser delivery systems, TruFocus laser indirect ophthalmoscopes, slit lamp adapters, and operating microscope adapters. Its ophthalmic delivery devices and other products also comprise EndoProbe, a fiber optic delivery device used for endophotocoagulation; G-Probe, a sterile single-use product used in procedures to treat medically and surgically uncontrolled glaucoma; DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears; GreenTip Soft Tip Cannula used to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

106 Employees
Last Reported Date: 04/2/15
Founded in 1989

iridex corp (IRIX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $387.4K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $323.5K
Vice President of Operations
Total Annual Compensation: $247.1K
Compensation as of Fiscal Year 2014.

iridex corp (IRIX) Key Developments

Icare Finland plc and Iridex Corporation Enter into Distribution Cooperation

Icare Finland Plc signed a distribution agreement with Iridex Corporation related to Icare's TA01i instrument. Iridex plans to package the Icare TA01i with the Iridex Total Glaucoma Solution which includes the newly launched Cyclo G6 laser and the proprietary MicroPulse P3 device dedicated specifically to treat patients diagnosed with a range of glaucoma disease states. The Icare TA01i aids the physician in the diagnosis of glaucoma as well as post-operative assessment and monitoring of the patient's intra-ocular pressure. Iridex sold its first new Cyclo G6 glaucoma laser along with MicroPulse P3 disposable devices during the first quarter of 2015. The MicroPulse P3 device offers a repeatable, minimally invasive approach to slowing the progress of the disease and pushing off the need for more invasive surgical intervention. The Icare TA01i tonometer revolutionizes effective, early glaucoma detection by making the intra-ocular pressure measuring routine quick and easy for the patient as well as the physician.

IRIDEX Corporation Announces Consolidated Unaudited Earnings Results for First Quarter Ended April 4, 2015; Provides Earnings Guidance for the Second Quarter and Revenue Guidance for the Full Year of 2015

IRIDEX Corporation announced consolidated unaudited earnings results for first quarter ended April 4, 2015. For the quarter, the company reported total revenues of $10,796,000, income from operations of $403,000, income from operations before provision for income taxes of $396,000, net income of $246,000 or $0.02 basic and diluted per share compared to the total revenues of $10,329,000, income from operations of $597,000, income from operations before provision for income taxes of $500,000, net income of $487,000 or $0.05 basic and diluted per share for the same quarter a year ago. The effective tax rate of 37.9% against effective tax rate was only 2.6% for the same period a year ago. The company expects to achieve revenue of $48 million to $51 million for the full year 2015, although the company will continue to assess the impact to its business of the recent strong currency adjustments on a global basis. For the 2015 second quarter, the company anticipates revenue of $10.7 million to $11.1 million, gross margin is anticipated to come in between 49% and 51%, and operating expenses are expected to be $5.0 million to $5.2 million.

IRIDEX Corporation to Report Q1, 2015 Results on May 07, 2015

IRIDEX Corporation announced that they will report Q1, 2015 results at 5:00 PM, US Eastern Standard Time on May 07, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $9.28 USD -0.31

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Anika Therapeutics Inc $33.62 USD -0.31
Ellex Medical Lasers Ltd A$0.34 AUD 0.00
STAAR Surgical Co $9.02 USD -0.06
Synergetics USA Inc $4.44 USD -0.01
Syneron Medical Ltd $11.03 USD -0.09
View Industry Companies
 

Industry Analysis

IRIX

Industry Average

Valuation IRIX Industry Range
Price/Earnings 10.0x
Price/Sales 2.2x
Price/Book 2.8x
Price/Cash Flow 9.8x
TEV/Sales 1.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit www.iridex.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.